Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia

Min Wang1, Ru Feng2, Jia-Min Zhang1

  • 1Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

Blood Advances
|May 5, 2019
PubMed

Insights

Immune thrombocytopenia (ITP) reduces platelet production by impairing megakaryocyte (MK) distribution in the bone marrow (BM) niche. Abnormal CXCL12/CXCR4 signaling and nestin+ MSC apoptosis contribute to these changes in ITP patients.

Area of Science:

  • Hematology
  • Immunology
  • Cell Biology

Background:

  • Immune thrombocytopenia (ITP) is characterized by impaired megakaryocyte (MK) maturation and reduced platelet production.
  • The specific alterations in bone marrow (BM) niche components and MK distribution in ITP remain incompletely understood.

Purpose of the Study:

  • To investigate the distribution and maturation of MKs within the BM niche in ITP.
  • To examine the regulatory components of the BM niche influencing MK migration in ITP.

Main Methods:

  • Analysis of BM and peripheral blood from 30 ITP patients and 28 healthy donors.
  • Sorting of nestin+ mesenchymal stem cells (MSCs) and CD41+ MKs via fluorescence-activated cell sorting.
  • Assessment of BM niche components and signaling pathways using immunofluorescence, flow cytometry, ELISA, RT-PCR, and Western blot.

Main Results:

  • Reduced number of MKs in the BM vascular niche and decreased CXCL12/CXCR4+ MKs in ITP patients.
  • Lower levels of nestin+ MSCs, CXCL12 mRNA, sympathetic nerves, Schwann cells, and β3-adrenoreceptor (β3-AR)+ nestin+ MSCs in ITP.
  • Increased apoptosis of nestin+ MSCs and reduced levels of matrix metalloproteinase 9, VEGF, and VEGF receptor 1 in ITP.

Conclusions:

  • Impaired MK distribution, driven by an abnormal CXCL12/CXCR4 axis, contributes to reduced platelet production in ITP.
  • Sympathetic neuropathy and nestin+ MSC apoptosis are implicated in the altered BM CXCL12 levels observed in ITP.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
What is the Immune System?01:38

What is the Immune System?

Overview
127.2K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.6K